The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

Note: This page is no longer being updated as of April 15, 2022 because our data provider has stopped collecting vaccination data. Current data can be found on the Public Health Agency of Canada ...

The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax’s updated protein-based vaccine targets the JN.1 subvariant of Omicron ...

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax’s updated protein-based vaccine targets the JN.1 subvariant of Omicron ...

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax's updated protein-based vaccine targets the JN.1 subvariant of Omicron ...

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax's updated protein-based vaccine targets the JN.1 subvariant of Omicron ...

The boosters are so-called “bivalent vaccines,” which are designed ... can be administered to people 12 and older, while Moderna Inc.’s Omicron booster is authorized for those 18 and older.